Wynn Capital LLC Makes New Investment in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Wynn Capital LLC purchased a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 3,003 shares of the company’s stock, valued at approximately $232,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Chicago Capital LLC raised its holdings in shares of GE HealthCare Technologies by 2.8% during the 3rd quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock worth $414,000 after acquiring an additional 163 shares in the last quarter. Chilton Capital Management LLC increased its stake in GE HealthCare Technologies by 15.4% in the fourth quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock worth $95,000 after purchasing an additional 164 shares during the period. Procyon Advisors LLC increased its stake in GE HealthCare Technologies by 5.2% in the fourth quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock worth $275,000 after purchasing an additional 175 shares during the period. Meeder Advisory Services Inc. increased its stake in GE HealthCare Technologies by 5.4% in the fourth quarter. Meeder Advisory Services Inc. now owns 3,634 shares of the company’s stock worth $281,000 after purchasing an additional 185 shares during the period. Finally, Forum Financial Management LP increased its stake in GE HealthCare Technologies by 3.9% in the third quarter. Forum Financial Management LP now owns 4,989 shares of the company’s stock worth $339,000 after purchasing an additional 186 shares during the period. 82.06% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. Morgan Stanley increased their price target on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research report on Monday, February 12th. Citigroup increased their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Argus increased their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. HSBC initiated coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They set a “buy” rating and a $100.00 price objective on the stock. Finally, Mizuho raised their price objective on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, April 11th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average price target of $95.09.

GE HealthCare Technologies Stock Performance

GEHC stock traded down $1.93 during trading on Thursday, hitting $84.79. 392,956 shares of the company traded hands, compared to its average volume of 3,303,960. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. The stock’s 50-day simple moving average is $88.91 and its 200 day simple moving average is $78.27. The company has a market cap of $38.69 billion, a PE ratio of 28.72, a P/E/G ratio of 3.00 and a beta of 0.94. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. The firm had revenue of $5.20 billion during the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business’s revenue was up 5.3% on a year-over-year basis. During the same period in the prior year, the firm earned $1.31 EPS. On average, equities analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a dividend of $0.03 per share. The ex-dividend date is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies’s payout ratio is 3.97%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.